At the American Association for the Study of Liver Diseases (AASLD) annual meeting, a session highlighted new guidance on ...

WASHINGTON -- Semaglutide (Wegovy) improved liver inflammation and fibrosis in patients with metabolic dysfunction-associated ...

This article was reviewed by Darragh O’Carroll, MD. Semaglutide Side Effects: What to Know Key takeaways: Common semaglutide ...

The race to develop the next generation of weight loss drugs has taken an interesting new turn. In recent research, Eli Lilly ...

At AHA 2025, data from the SCORE-HF study (NCT07141914) were presented, evaluating Novo Nordisk’s semaglutide 2.4mg and its ...

New research from the Technical University of Munich and Harvard Medical School reveals that popular GLP-1-based drugs, ...

Semaglutide therapy was associated with higher likelihood of passing low-risk cardiovascular thresholds among patients with ...

Novo Nordisk will strengthen its oral semaglutide portfolio led by Rybelsus while cutting Wegovy injection prices by up to 37 ...

Zydus Lifesciences Ltd and Torrent Pharmaceuticals Ltd are preparing to enter the fast-growing market for Semaglutide — a ...

New research reveals that tirzepatide and semaglutide both offer strong, early heart-protective effects. A major new ...

Oral semaglutide 25 mg was associated with improved glycemic parameters and cardiovascular risk across weight loss categories ...

The retrospective phase 2b study, which explored the use of various non-invasive tests (NITs) to assess response to semaglutide, adds to growing evidence that the drug not only improves metabolic ...